Aurora Daniele | Biochemistry | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Aurora Daniele | Biochemistry | Best Researcher Award

University of Naples Federico II | Italy

Prof. Dr. Aurora Daniele is an accomplished academic and researcher with more than three decades of contributions to the fields of molecular biology, genetics, and biochemistry. Currently serving as a Full Professor at the Università degli Studi di Napoli “Federico II,” she has established herself as an influential figure in biomedical sciences with a broad focus ranging from enzymatic pathways and protein biosynthesis to lysosomal storage disorders and molecular diagnostics. Her career reflects a remarkable blend of academic leadership, impactful research, and international collaboration. Prof. Daniele has published extensively in top-tier journals, authoring over 136 scientific papers indexed in Scopus, Web of Science, and PubMed. With an h-index of 30 and more than 2,700 citations, her research is widely recognized and cited globally. She has collaborated with institutions such as the Mayo Clinic in the United States and played a pivotal role as Principal Investigator at CEINGE – Biotecnologie Avanzate. Beyond research, she has contributed to academic governance, serving as President of the School of Food and Nutrition Sciences at the University of Campania “L. Vanvitelli.” Through her outstanding work, Prof. Daniele has significantly advanced knowledge in life sciences while shaping the next generation of scholars and practitioners.

Professinal Profile

Scopus | ORCID

Education

Prof. Dr. Aurora Daniele’s academic journey began with a strong foundation in the life sciences. She pursued her degree in Biological Sciences at the Università degli Studi di Napoli “Federico II,” where she developed a keen interest in molecular biology, genetics, and biochemical research. Her rigorous training at this historic university provided her with both theoretical depth and practical expertise, enabling her to engage in cutting-edge research from the early stages of her career. Following her initial studies, she sought advanced scientific exposure through national and international fellowships, most notably at the Telethon Institute of Genetics and Medicine in Milan, Italy. During this formative period, she focused on molecular diagnostics, genetic regulation, and the study of metabolic pathways. These opportunities enriched her scientific outlook, broadening her expertise in clinical molecular biology and the application of advanced biotechnological methods. Her educational background, deeply rooted in one of Italy’s oldest and most prestigious institutions, provided the strong academic and research orientation that continues to guide her career today. This blend of local academic grounding and global research training has allowed Prof. Daniele to establish herself as a thought leader in genetics and molecular diagnostics.

Professional Experience

Prof. Dr. Aurora Daniele has an extensive record of academic leadership and professional achievements. She currently serves as Full Professor at the Università degli Studi di Napoli “Federico II,” where she has taught and mentored undergraduate, graduate, and doctoral students in life sciences, biochemistry, and genetics. Her professional trajectory includes notable leadership roles, such as her tenure as President of the School of Food and Nutrition Sciences at the University of Campania “L. Vanvitelli”. In addition, she has contributed significantly to clinical and translational research as Principal Investigator at CEINGE – Biotecnologie Avanzate, an advanced biotechnology research center in Naples. Her professional career has been marked by consistent efforts to integrate molecular diagnostics into clinical applications, advancing both science and healthcare. Prof. Daniele has also played an essential role in fostering collaborations with international institutions, including the Mayo Clinic in the United States, thereby broadening the impact of her research beyond Italy. As an educator and scientist, she has successfully combined laboratory innovation with academic leadership, resulting in a career that influences policy, teaching, and medical practice. Her professional achievements highlight her as a leader in Italian and international biomedical research.

Research Interests

Prof. Dr. Aurora Daniele’s research interests lie at the intersection of molecular biology, genetics, and clinical biochemistry. Her work primarily focuses on enzymatic pathways, protein biosynthesis, and the molecular mechanisms underlying lysosomal storage disorders. She has dedicated significant research efforts to understanding genetic regulation and transcriptomic responses, with particular attention to the signaling pathways involved in metabolic and degenerative diseases. Another central aspect of her research is the development and application of molecular diagnostic tools aimed at identifying genetic disorders and optimizing clinical interventions. She is equally interested in transcriptomic and proteomic studies, which provide a broader systems-level understanding of disease pathophysiology. Over the years, Prof. Daniele has expanded her research to include clinical molecular diagnostics, with an emphasis on bridging laboratory science and patient care. She has also contributed to the study of nutritional sciences, linking metabolism to molecular pathways, thereby highlighting the interplay between diet, genetics, and health outcomes. Her wide-ranging interests have allowed her to contribute meaningfully to both fundamental science and applied medicine, positioning her as a key figure in advancing knowledge in biomedicine, diagnostics, and personalized healthcare.

Research Skills

Prof. Dr. Aurora Daniele possesses a highly diverse and advanced skill set in molecular biology, biochemistry, and genetics. She is proficient in enzymatic assays, protein expression and purification techniques, and the analysis of signaling pathways critical to cellular function. Her expertise extends to transcriptomic and proteomic technologies, enabling her to study gene expression regulation and protein interactions at a systems biology level. Additionally, she has advanced skills in clinical molecular diagnostics, which she has applied in both laboratory and translational settings to improve the detection and understanding of genetic disorders. Prof. Daniele is skilled in molecular cloning, PCR, electrophoresis, and biochemical analysis of cellular mechanisms. Her research also demonstrates proficiency in developing and validating biomarkers for disease, particularly in lysosomal storage disorders. Beyond laboratory methods, she is adept at scientific writing, project leadership, and cross-disciplinary collaboration, often integrating expertise from different research domains. Her ability to combine technical precision with conceptual innovation has made her a valuable contributor to both basic and applied research. These skills, acquired over decades of work, form the backbone of her impactful contributions to modern biomedical sciences.

Awards and Honors

Throughout her career, Prof. Dr. Aurora Daniele has received recognition for her exceptional contributions to biomedical research and academic leadership. She has been consistently acknowledged for her role in advancing molecular biology and clinical biochemistry, as well as for her leadership positions within prestigious Italian universities. Serving as President of the School of Food and Nutrition Sciences at the University of Campania “L. Vanvitelli” reflects her academic excellence and administrative capabilities. Her extensive publication record, with over 136 papers indexed in Scopus, PubMed, and Web of Science, further testifies to her global recognition. With an h-index of 30 and over 2,700 citations, her influence within the scientific community is substantial. Beyond metrics, she has been invited to collaborate with international research institutions, including the Mayo Clinic, underscoring the value of her expertise in global biomedical research. While specific awards and formal honors add to her distinction, her career itself stands as a testament to sustained excellence, mentorship, and leadership. Her recognition is rooted not only in academic circles but also in her meaningful impact on advancing diagnostics, therapeutic strategies, and higher education.

Publication Top Notes

  • Exploring the role of serum adiponectin and its holigomerization in fibrotic interstitial lung diseases: results from a cross-sectional study — 2025

  • β-Hydroxybutyrate mitigates the detrimental effects of high glucose in human retinal pigment epithelial ARPE-19 cells — 2025

  • Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn’s Disease Patients — 2025

  • Plasma adiponectin levels are associated with habitual dietary polyphenol intake in individuals at high cardiometabolic risk: a cross-sectional study — 2025

  • Exploring the Link Between Psoriasis and Adipose Tissue: One Amplifies the Other — 2024 — 2 citations

  • Impact of Lifestyle Interventions on Multiple Sclerosis: Focus on Adipose Tissue — 2024 — 3 citations

  • Effects of Exhaustive Exercise on Adiponectin and High-Molecular-Weight Oligomer Levels in Male Amateur Athletes — 2024 — 1 citation

  • LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa — 2024 — 3 citations

Conclusion

Prof. Dr. Aurora Daniele exemplifies the qualities of an outstanding researcher, educator, and leader in the fields of molecular biology, genetics, and biochemistry. With a career spanning more than three decades, she has consistently contributed to advancing both fundamental science and applied clinical practices. Her extensive research output, collaborations with international institutions, and leadership roles within Italian academia reflect her ability to integrate innovation, mentorship, and governance. She has effectively bridged laboratory research with healthcare applications, particularly in molecular diagnostics and metabolic disorders, thereby enhancing both scientific understanding and patient outcomes. Her skills, ranging from enzymatic assays to proteomic studies, highlight her versatility and technical excellence, while her publication record demonstrates her influence and recognition within the global scientific community. Prof. Daniele’s dedication to education has further amplified her impact, preparing the next generation of scientists and healthcare professionals. Her professional journey underscores a balance of academic rigor, international collaboration, and scientific creativity, making her a true leader in biomedical sciences. With her ongoing research and visionary outlook, she continues to shape the future of diagnostics, molecular medicine, and higher education, deserving recognition at the highest levels.

Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Published on by Shen Awards

Prof. Dr. Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Professor of Physiology from Institute of Laboratory Animal Sciences, China

Professor Jiang Xiaoliang is a distinguished researcher and Master’s Supervisor at the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences. Born in March 1987, he has built an impressive career in cardiovascular research, laboratory animal sciences, and molecular mechanisms underlying hypertension and cardiac disorders. With over a decade of dedicated research, he has contributed significantly to understanding the role of epigenetic regulation, signal transduction pathways, and disease modeling. His extensive experience in both national and international institutions has led to numerous high-impact publications in prestigious journals such as Advanced Science, Hypertension, and the Journal of the American Heart Association. Additionally, he has successfully led and participated in major research projects funded by the National Natural Science Foundation of China and the Chinese Academy of Medical Sciences. Professor Jiang’s work demonstrates a seamless integration of experimental pathology, physiology, and translational medicine. His contributions have been recognized through several awards and honors, affirming his role as a leading scholar in his field. Jiang’s continuous commitment to innovation and excellence marks him as a highly suitable candidate for distinguished research awards. His profile reflects both depth and breadth of expertise, making him a role model for aspiring scientists.

Professional Profile

Education

Professor Jiang Xiaoliang has pursued a focused and prestigious educational path aligned with his research interests in pathology, physiology, and biological sciences. He obtained his Ph.D. in Pathology and Pathophysiology from the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, between September 2011 and July 2014. His doctoral studies allowed him to develop an in-depth understanding of disease mechanisms at the molecular and cellular levels, particularly within the cardiovascular system. Before his Ph.D., he earned his M.S. in Physiology from the same institute between September 2009 and July 2011, further enhancing his knowledge of bodily functions and their disruptions in disease states. His academic journey began with a B.S. in Biological Science from Shandong Normal University, completed from September 2005 to July 2009. This strong foundational background equipped him with a broad knowledge of biological principles, critical thinking skills, and experimental methodologies, setting the stage for his later specialized training. Throughout his education, Professor Jiang demonstrated academic excellence and a commitment to scientific inquiry. His educational trajectory reflects a consistent dedication to advancing his expertise in biomedical sciences, perfectly positioning him for a leading role in cutting-edge medical research.

Professional Experience

Professor Jiang Xiaoliang’s professional career is deeply rooted in the Institute of Laboratory Animal Sciences at the Chinese Academy of Medical Sciences, where he has progressively advanced through academic and research roles. Currently, he serves as a Researcher since December 2024, leading key projects and supervising postgraduate research. Previously, he was an Associate Researcher from July 2018 to December 2024, where he contributed to significant research programs and established a strong reputation in cardiovascular and hypertension research. From January 2014 to July 2018, he worked as an Assistant Researcher, during which he honed his skills in experimental design, molecular biology techniques, and disease modeling. Notably, Professor Jiang also gained international experience as a Research Assistant at the University of Maryland School of Medicine, Department of Nephrology, from August 2012 to January 2014. This exposure to an international research environment broadened his perspectives and enriched his scientific approaches. Across all his roles, Professor Jiang has demonstrated outstanding leadership, technical expertise, and a passion for translational research. His career progression reflects a consistent commitment to excellence, making significant contributions to the fields of laboratory animal science and cardiovascular medicine.

Research Interests

Professor Jiang Xiaoliang’s research interests focus primarily on cardiovascular diseases, molecular and cellular mechanisms of hypertension, cardiac hypertrophy, renal physiology, and laboratory animal model development. He is particularly interested in the epigenetic regulation of cardiac reprogramming, the role of ion channels in blood pressure regulation, and the impact of neurohormonal factors on cardiovascular health. His work explores how pathways like PI3K/Akt, PKC-mediated signaling, and Na+/H+ exchangers contribute to disease pathology, and how these mechanisms can be targeted therapeutically. Additionally, he has investigated the interplay between salt sensitivity, inflammation, and oxidative stress in the development of hypertension. Another key area of his research includes the establishment and refinement of animal models for infectious and cardiovascular diseases, aiding in the development of new therapeutic interventions. His focus on translational medicine bridges basic research findings with potential clinical applications. Furthermore, Jiang has demonstrated a keen interest in the interactions between dopamine receptor pathways and cardiovascular-renal function. Through his research, he aims to uncover novel insights that can lead to innovative treatments for complex and critical diseases.

Research Skills

Professor Jiang Xiaoliang possesses an extensive array of research skills that have greatly enhanced his scientific contributions. His expertise includes molecular biology techniques such as gene editing, nucleic acid delivery, and signal transduction pathway analysis. He is proficient in developing and utilizing animal models for cardiovascular and infectious disease studies, a critical skill in translational medicine. Jiang has demonstrated advanced capabilities in histopathology, immunohistochemistry, real-time PCR, Western blotting, and other biochemical assays essential for mechanistic studies. He is highly skilled in the analysis of epigenetic modifications and their effects on gene expression, particularly concerning cardiac reprogramming and vascular biology. Additionally, his experience includes the application of pharmacological interventions and gene therapy techniques to elucidate disease pathways and therapeutic targets. Professor Jiang’s international research experience has provided him with strong data management, statistical analysis, and collaborative project management skills. His ability to design, implement, and analyze complex experiments underscores his strength in bridging basic research with clinical relevance. Through his technical proficiency and innovative approach, Jiang continues to push the boundaries of biomedical research.

Awards and Honors

Professor Jiang Xiaoliang’s outstanding contributions to science have been recognized through numerous prestigious awards and honors. In 2022, he was awarded the “Young International Award” by the Japanese Association for Laboratory Animal Science, a testament to his significant impact on the field at an early career stage. Additionally, he received the Second Prize of the Science and Technology Achievement Award from the Chinese Association for Laboratory Animals for his role in the “Creation and Application of Animal Models for Cardiovascular Diseases.” Another notable recognition was the Second Prize of the Hebei Provincial Science and Technology Progress Award in 2019, for his work on the regulation of the Renin-Angiotensin System in multiple organ injuries. Jiang was also selected for the highly competitive Youth Talent Support Project (YESS20170157) under the China Association for Life Sciences, where he secured ¥450,000 in funding for innovative research from 2017 to 2019. These honors reflect Professor Jiang’s consistent excellence, innovation, and leadership in biomedical research. His recognition by national and international bodies illustrates his important role in advancing scientific knowledge and his strong potential for future groundbreaking contributions.

Conclusion

In conclusion, Professor Jiang Xiaoliang stands out as a highly qualified and accomplished scholar in the field of biomedical sciences, particularly cardiovascular research and laboratory animal science. His educational background, combined with extensive professional experience and a strong record of research achievements, positions him as a leader and innovator in his discipline. His ability to secure competitive funding, produce high-impact publications, and contribute meaningfully to collaborative research initiatives highlights both his scientific capabilities and leadership qualities. Professor Jiang’s recognition through various prestigious awards further attests to his contributions to the advancement of science. His research exhibits a rare combination of depth, innovation, and translational relevance. Areas where he might further strengthen his profile include expanding international collaborations and leading multi-center studies to enhance global scientific impact. Overall, Professor Jiang’s impressive career trajectory, commitment to excellence, and passion for discovery make him a strong and deserving candidate for the Best Scholar Award in Research. He embodies the qualities of an outstanding researcher who continues to make significant contributions to medical science and inspire the next generation of scientists.

Publications Top Notes

  1. Title: Enpp1 Ameliorates MAFLD by Regulating Hepatocyte Lipid Metabolism Through the AMPK/PPARα Signaling Pathway

    • Authors: Liu Xiaohui, Chen Shuai, Liu Xing, Li Yuhan, Yang Zhiwei

    • Year: 2025

  2. Title: Intestinal Gastrin/CCKBR Axis Protects Against Type 2 Diabetes by Reducing Intestinal Glucose Absorption Through the PI3K/Akt/eIF4B Signaling Pathway

    • Authors: Liu Xue, Liu Xing, Liu Yunpeng, Zhang Haizeng, Yang Zhiwei

    • Year: 2025

Fu Xiaocong | Molecular Biology | Best Innovation Award

Published on by Shen Awards

Mr. Fu Xiaocong | Molecular Biology | Best Innovation Award

Shanghai Paisi Xin Biopharmaceutical Technology Co., Ltd. Malaysia

Dr. Xiaocong Fu is a highly accomplished Senior Tumor Immunology Researcher with more than a decade of experience in the development of cell therapy and gene/nucleic acid-based therapeutics. Currently based in Shanghai, he holds a PhD and has served in both academic and industrial roles, including as Founder of PSM Biotech and Associate Professor at Taylor’s University. His career encompasses a broad range of translational research activities with a strong focus on clinical immunology, drug mechanism validation, and precision oncology. He has published over 30 academic papers, with 13 as the first author in SCI-indexed journals, and holds more than nine personal invention patents. Dr. Fu is certified in GCP, CAP auditing, and biosafety regulations, with additional advisory roles in AI research and biotechnology projects. His multifaceted expertise includes immune function analysis, CAR-T/TCR-T method development, and organoid model systems, all of which reflect his dedication to innovation and real-world impact. His unique ability to combine clinical relevance with scientific discovery positions him as a leading figure in the field of tumor immunology and a strong candidate for prestigious innovation and research awards.

Professional Profile

Education

Dr. Xiaocong Fu holds a Doctorate in Tumor Immunology, which has laid the scientific foundation for his highly specialized career in immunotherapy research. In addition to his academic training in immunology, he pursued advanced studies in business and innovation management at the China Europe International Business School, equipping him with a strategic understanding of biotech commercialization and research leadership. This interdisciplinary educational background has uniquely positioned him to integrate laboratory innovation with real-world therapeutic applications. His formal training includes rigorous technical and regulatory coursework, exemplified by certifications in Good Clinical Practice (GCP) and clinical trial quality management. Dr. Fu has also completed specialized training in biosafety and laboratory quality systems, including certification from the Shanghai Biosafety Training and Assessment Program and the College of American Pathologists (CAP). These credentials have enabled him to oversee clinical laboratory standards and contribute to high-stakes regulatory audits and clinical research. His academic affiliation with Taylor’s University as an Associate Professor further demonstrates his commitment to continuous learning, academic mentorship, and scientific excellence. The combination of scientific rigor and managerial insight distinguishes Dr. Fu’s educational journey and reflects his preparedness to drive complex, multidisciplinary projects in immunology and therapeutic development.

Professional Experience

Dr. Xiaocong Fu’s professional journey spans more than a decade of progressive responsibility in both industry and academia, reflecting a strong blend of translational research and entrepreneurial leadership. From 2012 to 2019, he worked at Shanghai WuXi AppTec Co., Ltd., where he played a critical role in preclinical and clinical immunology research. His responsibilities included the development of orthotopic tumor models, pharmacokinetic/pharmacodynamic studies, immune function assays, and clinical biomarker validation. During this time, he built expertise in flow cytometry, immune subpopulation analysis, and organoid construction platforms. As Technical Director of the CAP Clinical Center, Dr. Fu successfully developed and validated multiple clinical methods, including those for CAR-T therapies and phosphorylation-related biomarker detection. His current roles include Founder of PSM Biotech, where he leads innovation in cell and gene therapy platforms, and Associate Professor at Taylor’s University, where he contributes to academic research and mentorship. He also serves as Vice President of the Jiangxi Chamber of Commerce and holds advisory roles with AI research institutes. Dr. Fu’s professional scope covers scientific innovation, quality control, clinical trial management, and biotech entrepreneurship, establishing him as a multifaceted leader in the biomedical and pharmaceutical research sectors.

Research Interests

Dr. Xiaocong Fu’s research interests lie at the forefront of tumor immunology, cell therapy development, and translational clinical science. His primary focus is on understanding the mechanisms of immune response in cancer, particularly through the development and validation of CAR-T and TCR-T therapies. He is deeply involved in immune-mediated killing analyses, including ADCC (antibody-dependent cellular cytotoxicity), CDC (complement-dependent cytotoxicity), ADCP (antibody-dependent cellular phagocytosis), and TLR (toll-like receptor) functions. Dr. Fu also explores immune phenotyping and biomarker discovery, especially in relation to hematological malignancies and solid tumors. Another key area of interest is the use of induced pluripotent stem cells (iPSCs) for disease modeling and drug response simulation, with his team constructing organoid platforms for more precise in vitro analyses. Additionally, he is passionate about integrating gene editing technologies such as CRISPR to develop immune cell-based models that mimic in vivo responses. Dr. Fu’s interests extend to clinical pharmacology, biomarker-based patient stratification, and receptor occupancy studies, all aimed at creating more effective, personalized therapeutic strategies. His research is inherently translational, bridging the gap between laboratory innovation and clinical application to improve patient outcomes in cancer immunotherapy.

Research Skills

Dr. Xiaocong Fu possesses a wide array of advanced research skills that make him a standout contributor in the field of tumor immunology and clinical translational research. He is proficient in both in vitro and in vivo assays, including the development of orthotopic tumor models and functional immune assays. He has mastered multiparameter flow cytometry and is capable of operating high-throughput cytometry instruments such as the BD Fortessa X-20 and Canto systems, applying panels with up to 18 colors. His skill set includes the quantitative analysis of intracellular and extracellular signaling molecules, using detection platforms like Cytometric Bead Array (CBA) and Meso Scale Discovery (MSD). Dr. Fu is experienced in gene editing using CRISPR/Cas9 technologies, having successfully developed monoclonal iPSCs with precise gene knock-ins/knockouts. In clinical pharmacology, he has validated several PK/PD methods for CAR-T therapies and phosphorylation biomarkers. His technical leadership extends to immunophenotyping of both lymphoid and myeloid subpopulations, receptor occupancy assays, and biomarker tracking. He is also adept at clinical laboratory quality systems, having contributed to CAP audits and biosafety program implementations. These diverse, high-level research skills have enabled him to lead multidisciplinary projects across discovery, validation, and clinical translation domains.

Awards and Honors

Throughout his career, Dr. Xiaocong Fu has received numerous accolades that highlight his commitment to excellence and innovation in biomedical research. While specific award titles are not listed in the provided profile, his recognition can be inferred from his leadership roles and scientific achievements. His appointment as an Associate Professor at Taylor’s University, a position typically awarded to individuals with significant academic contributions, underscores his research credibility. His selection as a CAP auditor and a GCP-certified clinical trial manager reflects the high level of trust regulatory and research bodies place in his judgment and technical competence. As the Founder of PSM Biotech, he has also been acknowledged for his entrepreneurial efforts in translating immunological science into therapeutic platforms. Moreover, his advisory role in AI-based scientific projects further demonstrates peer recognition of his interdisciplinary expertise. With over 13 first-author SCI publications and nine personal invention patents, Dr. Fu’s body of work stands as a testament to sustained scholarly and innovative output. These milestones serve as informal yet powerful recognitions of his contributions, suggesting that he is not only a subject matter expert but also a recognized leader in his field.

Conclusion

Dr. Xiaocong Fu exemplifies the fusion of scientific excellence, clinical relevance, and innovative thinking necessary to transform cancer therapy through immune system modulation. His rich educational background, expansive professional experience, and cutting-edge research portfolio position him at the forefront of biomedical innovation. From pioneering CAR-T and TCR-T therapies to constructing iPSC-based organoid models, his work covers the full spectrum of research from basic science to translational application. As a skilled researcher, technical leader, and biotech entrepreneur, Dr. Fu has developed and validated multiple clinical methodologies, driven discovery in tumor immunology, and fostered collaborations across academia, industry, and regulatory agencies. His research consistently addresses real-world challenges in oncology and immunotherapy, leveraging both molecular precision and systems-level insight. Although there is room to expand his visibility in global academic networks and enhance commercialization outcomes, Dr. Fu’s existing contributions are both impactful and future-focused. He is a model candidate for honors such as the Best Innovation Award in Research and represents the caliber of researcher who not only advances knowledge but also changes lives through science.